![Charles Hecker](/-/media/corporate/images/who-we-are/our-experts/90x90/charles-hecker-90x90.png?h=90&w=90&la=en&hash=EEFFB6DC8E6441FC4848580E6D7DEF02)
Our Thinking
Vaccines: the road ahead
Vaccines: the road ahead
The UK approved the first COVID-19 vaccine in early December, and the pandemic entered a new phase. While this is certainly a moment for optimism, vaccines bring new challenges around efficacy, distribution and public resistance. This week’s panel includes Caroline Naumann, Associate Director for Crisis and Security Consulting and also our COVID-19 Advisory Lead in EMEA, and Joseph Smith, Senior Analyst responsible for providing analysis on international business issues as well as one of our leaders on analysis of the vaccine rollout.